Hematopoietic Stem Cells (HSCs) Market Report

Global and Region Hematopoietic Stem Cells (HSCs) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：179
  • REPORT CODE：GMM939514
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Hematopoietic Stem Cells (HSCs) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Hematopoietic Stem Cells (HSCs)market, defines the market attractiveness level of Hematopoietic Stem Cells (HSCs) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Hematopoietic Stem Cells (HSCs) industry, describes the types of Hematopoietic Stem Cells (HSCs) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hematopoietic Stem Cells (HSCs) market and the development prospects and opportunities of Hematopoietic Stem Cells (HSCs) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hematopoietic Stem Cells (HSCs) market in Chapter 13.

    By Player:

    • PromoCell

    • Vcanbio

    • Cesca Therapeutics Inc

    • Kite Pharma Inc

    • Beike Biotechnology

    • ScienCell Research Laboratories

    • Genlantis

    • R&D Systems

    • Thermo Fisher Scientific

    • Boyalife

    • Lonza Group Ltd

    • CellGenix Technologie Transfer GmbH

    • China Cord Blood Corporation

    • TiGenix NV

    By Type:

    • Leukocyte

    • Lymphocytes

    • Red Blood Cells

    • Platelets

    By End-User:

    • Blood System Diseases

    • Autoimmune Diseases

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Hematopoietic Stem Cells (HSCs) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Hematopoietic Stem Cells (HSCs) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Hematopoietic Stem Cells (HSCs) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Hematopoietic Stem Cells (HSCs) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Hematopoietic Stem Cells (HSCs) Market Analysis and Outlook to 2022

    • 7.1 Global Hematopoietic Stem Cells (HSCs) Consumption (2017-2022)

    • 7.2 United States Hematopoietic Stem Cells (HSCs) Consumption (2017-2022)

    • 7.3 Europe Hematopoietic Stem Cells (HSCs) Consumption (2017-2022)

    • 7.4 China Hematopoietic Stem Cells (HSCs) Consumption (2017-2022)

    • 7.5 Japan Hematopoietic Stem Cells (HSCs) Consumption (2017-2022)

    • 7.6 India Hematopoietic Stem Cells (HSCs) Consumption (2017-2022)

    • 7.7 South Korea Hematopoietic Stem Cells (HSCs) Consumption (2017-2022)

    8 Region and Country-wise Hematopoietic Stem Cells (HSCs) Market Analysis and Outlook to 2028

    • 8.1 Global Hematopoietic Stem Cells (HSCs) Consumption Forecast (2022-2028)

    • 8.2 United States Hematopoietic Stem Cells (HSCs) Consumption Forecast (2022-2028)

    • 8.3 Europe Hematopoietic Stem Cells (HSCs) Consumption Forecast (2022-2028)

    • 8.4 China Hematopoietic Stem Cells (HSCs) Consumption Forecast (2022-2028)

    • 8.5 Japan Hematopoietic Stem Cells (HSCs) Consumption Forecast (2022-2028)

    • 8.6 India Hematopoietic Stem Cells (HSCs) Consumption Forecast (2022-2028)

    • 8.7 South Korea Hematopoietic Stem Cells (HSCs) Consumption Forecast (2022-2028)

    9 Global Hematopoietic Stem Cells (HSCs) Market Outlook by Types and Applications to 2022

    • 9.1 Global Hematopoietic Stem Cells (HSCs) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Leukocyte Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Lymphocytes Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Red Blood Cells Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Platelets Consumption and Growth Rate (2017-2022)

    • 9.2 Global Hematopoietic Stem Cells (HSCs) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Blood System Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Hematopoietic Stem Cells (HSCs) Market Outlook by Types and Applications to 2028

    • 10.1 Global Hematopoietic Stem Cells (HSCs) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Leukocyte Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Lymphocytes Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Red Blood Cells Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Platelets Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Hematopoietic Stem Cells (HSCs) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Blood System Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Hematopoietic Stem Cells (HSCs) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Hematopoietic Stem Cells (HSCs) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Hematopoietic Stem Cells (HSCs) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Hematopoietic Stem Cells (HSCs) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Hematopoietic Stem Cells (HSCs) Market Competitive Analysis

    • 14.1 PromoCell

      • 14.1.1 PromoCell Company Details

      • 14.1.2 PromoCell Hematopoietic Stem Cells (HSCs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 PromoCell Hematopoietic Stem Cells (HSCs) Product and Service

    • 14.2 Vcanbio

      • 14.2.1 Vcanbio Company Details

      • 14.2.2 Vcanbio Hematopoietic Stem Cells (HSCs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Vcanbio Hematopoietic Stem Cells (HSCs) Product and Service

    • 14.3 Cesca Therapeutics Inc

      • 14.3.1 Cesca Therapeutics Inc Company Details

      • 14.3.2 Cesca Therapeutics Inc Hematopoietic Stem Cells (HSCs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Cesca Therapeutics Inc Hematopoietic Stem Cells (HSCs) Product and Service

    • 14.4 Kite Pharma Inc

      • 14.4.1 Kite Pharma Inc Company Details

      • 14.4.2 Kite Pharma Inc Hematopoietic Stem Cells (HSCs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Kite Pharma Inc Hematopoietic Stem Cells (HSCs) Product and Service

    • 14.5 Beike Biotechnology

      • 14.5.1 Beike Biotechnology Company Details

      • 14.5.2 Beike Biotechnology Hematopoietic Stem Cells (HSCs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Beike Biotechnology Hematopoietic Stem Cells (HSCs) Product and Service

    • 14.6 ScienCell Research Laboratories

      • 14.6.1 ScienCell Research Laboratories Company Details

      • 14.6.2 ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Product and Service

    • 14.7 Genlantis

      • 14.7.1 Genlantis Company Details

      • 14.7.2 Genlantis Hematopoietic Stem Cells (HSCs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Genlantis Hematopoietic Stem Cells (HSCs) Product and Service

    • 14.8 R&D Systems

      • 14.8.1 R&D Systems Company Details

      • 14.8.2 R&D Systems Hematopoietic Stem Cells (HSCs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 R&D Systems Hematopoietic Stem Cells (HSCs) Product and Service

    • 14.9 Thermo Fisher Scientific

      • 14.9.1 Thermo Fisher Scientific Company Details

      • 14.9.2 Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Product and Service

    • 14.10 Boyalife

      • 14.10.1 Boyalife Company Details

      • 14.10.2 Boyalife Hematopoietic Stem Cells (HSCs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Boyalife Hematopoietic Stem Cells (HSCs) Product and Service

    • 14.11 Lonza Group Ltd

      • 14.11.1 Lonza Group Ltd Company Details

      • 14.11.2 Lonza Group Ltd Hematopoietic Stem Cells (HSCs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Lonza Group Ltd Hematopoietic Stem Cells (HSCs) Product and Service

    • 14.12 CellGenix Technologie Transfer GmbH

      • 14.12.1 CellGenix Technologie Transfer GmbH Company Details

      • 14.12.2 CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Product and Service

    • 14.13 China Cord Blood Corporation

      • 14.13.1 China Cord Blood Corporation Company Details

      • 14.13.2 China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Product and Service

    • 14.14 TiGenix NV

      • 14.14.1 TiGenix NV Company Details

      • 14.14.2 TiGenix NV Hematopoietic Stem Cells (HSCs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 TiGenix NV Hematopoietic Stem Cells (HSCs) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Hematopoietic Stem Cells (HSCs)

    • Figure Hematopoietic Stem Cells (HSCs) Picture

    • Table Global Hematopoietic Stem Cells (HSCs) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Hematopoietic Stem Cells (HSCs) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Hematopoietic Stem Cells (HSCs) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Hematopoietic Stem Cells (HSCs) Consumption by Country (2017-2022)

    • Figure United States Hematopoietic Stem Cells (HSCs) Consumption and Growth Rate (2017-2022)

    • Table Europe Hematopoietic Stem Cells (HSCs) Consumption and Growth Rate (2017-2022)

    • Figure China Hematopoietic Stem Cells (HSCs) Consumption and Growth Rate (2017-2022)

    • Figure Japan Hematopoietic Stem Cells (HSCs) Consumption and Growth Rate (2017-2022)

    • Figure India Hematopoietic Stem Cells (HSCs) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Hematopoietic Stem Cells (HSCs) Consumption and Growth Rate (2017-2022)

    • Figure Global Hematopoietic Stem Cells (HSCs) Consumption Forecast by Country (2022-2028)

    • Figure United States Hematopoietic Stem Cells (HSCs) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Hematopoietic Stem Cells (HSCs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Hematopoietic Stem Cells (HSCs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Hematopoietic Stem Cells (HSCs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Hematopoietic Stem Cells (HSCs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Hematopoietic Stem Cells (HSCs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Leukocyte Consumption and Growth Rate (2017-2022)

    • Figure Global Lymphocytes Consumption and Growth Rate (2017-2022)

    • Figure Global Red Blood Cells Consumption and Growth Rate (2017-2022)

    • Figure Global Platelets Consumption and Growth Rate (2017-2022)

    • Figure Global Blood System Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Leukocyte Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lymphocytes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Red Blood Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Platelets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood System Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Hematopoietic Stem Cells (HSCs) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Hematopoietic Stem Cells (HSCs) Export by Region (Top 5 Countries) (2017-2028)

    • Table PromoCell (Foundation Year, Company Profile and etc.)

    • Table PromoCell Hematopoietic Stem Cells (HSCs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table PromoCell Hematopoietic Stem Cells (HSCs) Product and Service

    • Table Vcanbio (Foundation Year, Company Profile and etc.)

    • Table Vcanbio Hematopoietic Stem Cells (HSCs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vcanbio Hematopoietic Stem Cells (HSCs) Product and Service

    • Table Cesca Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Cesca Therapeutics Inc Hematopoietic Stem Cells (HSCs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cesca Therapeutics Inc Hematopoietic Stem Cells (HSCs) Product and Service

    • Table Kite Pharma Inc (Foundation Year, Company Profile and etc.)

    • Table Kite Pharma Inc Hematopoietic Stem Cells (HSCs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kite Pharma Inc Hematopoietic Stem Cells (HSCs) Product and Service

    • Table Beike Biotechnology (Foundation Year, Company Profile and etc.)

    • Table Beike Biotechnology Hematopoietic Stem Cells (HSCs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beike Biotechnology Hematopoietic Stem Cells (HSCs) Product and Service

    • Table ScienCell Research Laboratories (Foundation Year, Company Profile and etc.)

    • Table ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Product and Service

    • Table Genlantis (Foundation Year, Company Profile and etc.)

    • Table Genlantis Hematopoietic Stem Cells (HSCs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genlantis Hematopoietic Stem Cells (HSCs) Product and Service

    • Table R&D Systems (Foundation Year, Company Profile and etc.)

    • Table R&D Systems Hematopoietic Stem Cells (HSCs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table R&D Systems Hematopoietic Stem Cells (HSCs) Product and Service

    • Table Thermo Fisher Scientific (Foundation Year, Company Profile and etc.)

    • Table Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Product and Service

    • Table Boyalife (Foundation Year, Company Profile and etc.)

    • Table Boyalife Hematopoietic Stem Cells (HSCs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boyalife Hematopoietic Stem Cells (HSCs) Product and Service

    • Table Lonza Group Ltd (Foundation Year, Company Profile and etc.)

    • Table Lonza Group Ltd Hematopoietic Stem Cells (HSCs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lonza Group Ltd Hematopoietic Stem Cells (HSCs) Product and Service

    • Table CellGenix Technologie Transfer GmbH (Foundation Year, Company Profile and etc.)

    • Table CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Product and Service

    • Table China Cord Blood Corporation (Foundation Year, Company Profile and etc.)

    • Table China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Product and Service

    • Table TiGenix NV (Foundation Year, Company Profile and etc.)

    • Table TiGenix NV Hematopoietic Stem Cells (HSCs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table TiGenix NV Hematopoietic Stem Cells (HSCs) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US